Search

everythinglearnresearchcommunity

for

Search:↓

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Using more minoxidil solution can lead to better hair growth, but people often use only half the recommended amount. Education and motivation can improve results.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Topical treatments led to hair regrowth in a man with linear morphea.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Patients with chronic skin disorders often experience depression, anxiety, and reduced quality of life and may benefit from psychiatric help.

Vitamin D is important for skin health, but more research is needed to understand its full effects and treatment potential.

Patients with ichthyosis often experience symptoms similar to psoriasis and atopic dermatitis, suggesting that targeted therapies could improve their condition.

People with hidradenitis suppurativa are more likely to have bipolar disorder than those with psoriasis or without skin conditions.

IMA and IMA/albumin levels don't predict alopecia areata severity.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Azelaic acid treats acne, rosacea, and hyperpigmentation with minimal side effects.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Scalp disease in dermatomyositis causes significant symptoms and has unique features.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.